Skip to content
Recall Observatory FDA recall evidence

Drug product

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

D-067-2013

November 05, 2012

Class II

Product summary

Firm
Boehringer Ingelheim Roxane Inc
Event
Event 63630
Status
Terminated
Classification
Class II
Quantity
8,381 bottles
Official record key
drug-enforcement:D-067-2013

Official wording

Reason: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Code information: Lot 201900 Expiration Date: JAN 2015

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Field note

Send feedback

We'll only use this to respond to your feedback.